
Inflammation: the immune system's life-sustaining spark that can drive disease
A New York Times Magazine piece explains that chronic low-grade inflammation is a key driver of aging-related illnesses (cancer, diabetes, Alzheimer’s) and is not a single disease but a complex web of immune activity centered on macrophages. The concept of inflammaging describes how aging immune cells become less efficient, potentially paving the way for disease; anti-inflammatory therapies show promise but carry risks (e.g., infection). GLP-1 drugs used for diabetes and weight loss appear to reduce systemic inflammation and improve various conditions, while new real‑time inflammation monitors could let people track and manage inflammatory risk. The takeaway is that prevention (diet, exercise, sleep) remains vital, and scientists aim to integrate multi-system data to better understand and treat chronic inflammation without compromising immunity.












